Philippines to start clinical trials on ivermectin, other drugs for COVID-19


FILE PHOTO: A pharmacist holds the anti-parasite drug ivermectin for sale to the public with a medical prescription as Bolivia's Ministry of Health said it can be used under proper medical protocol, while noting the lack of evidence for it as a treatment for the coronavirus disease (COVID-19) in Santa Cruz, Bolivia May 19, 2020. REUTERS/Rodrigo Urzagasti

MANILA (Reuters) - The Philippines will begin clinical trial of several drugs, including the anti-parasite medication ivermectin, in patients with COVID-19 to determine their efficacy in combatting the coronavirus, a senior government official said.

Some politicians in the Philippines have started promoting the use of ivermectin for coronavirus and given out free doses, although the country's food and drugs regulator has cautioned against the use because of a lack of evidence for the drug as a treatment.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

North Sea temperature off Dutch coast hits record high: statistics
Lebanon hands Assad-era general to Syria in first such transfer since Assad’s fall
U.S. stocks close higher
Trump the builder carves his legacy in stone as pressures mount
African Swine Fever cases in wild boar rise, disrupting Finland's pork export
Urgent: U.S. national debt tops 40 trillion USD: Treasury Department
Flash: U.S. national debt tops 40 trillion USD: Treasury Department
Latvian president seeks prosecutor's review after massive data breach
Libya issues new regulations for foreign educational institutions
Crude futures settle higher

Others Also Read